$547.03
-0.86-0.16%
Last update: Nov 11, 5:48 PM
Vertex Pharmaceuticals Inc (VRTX) Stock Price, Quote, News & History
VRTXNASDAQ
Vertex missed Q3 EPS estimates but beat sales, raised FY2026 guidance, and shares rose 2.7% as analysts lifted price targets.
You can purchase shares of Vertex Pharmaceuticals (NASDAQ:VRTX) through any online brokerage.
Other companies in Vertex Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Moderna Inc (NASDAQ:MRNA).
Vertex Pharmaceuticals has a consensus price target of $565.84.
The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $546.61 last updated November 11, 2026 at 5:48 PM EST.
There are no upcoming dividends for Vertex Pharmaceuticals.
Vertex Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Vertex Pharmaceuticals.
Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis,...
